While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the use of AI in clinical trials, the technology is still le ...

AI can streamline clinical trials, but it’s not without risks ... Additionally, compliance with HIPAA and other privacy regulations is imperative. Pharmaceutical companies must thoroughly ...

Incorporating AI into various processes might make clinical trials more efficient, but it also exposes another front for hackers to attack. Regulations such as the European Union’s GDPR also ...

Clinical trials are becoming increasingly complex, with a growing volume of data, forms, and regulations to manage ... for key insights into how AI is transforming workflows to help address ...

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials. From patient ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.